Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.

The affibody functionalization of fluorescent surface-enhanced Raman scattering gold-silica nanoparticles as multimodal contrast agents for molecular imaging specific to epidermal growth factor receptor (EGFR) is reported. This nanoparticle bioconjugate reports EGFR-positive A431 tumors with a signal nearly 35-fold higher than EGFR-negative MDA-435S tumors. The low-level EGFR expression in adjacent healthy tissue is 7-fold lower than in the positive tumors. Validation via competitive inhibition reduces the signal by a factor of six, and independent measurement of EGFR via flow cytometry correlates at R(2) = 0.92.

[1]  L M Schuman,et al.  The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.

[2]  Olga Lyandres,et al.  Progress toward an in vivo surface-enhanced Raman spectroscopy glucose sensor. , 2008, Diabetes technology & therapeutics.

[3]  G. Whitesides,et al.  A Survey of Structure−Property Relationships of Surfaces that Resist the Adsorption of Protein , 2001 .

[4]  V. Chernomordik,et al.  Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging , 2008, Clinical Cancer Research.

[5]  D. Lieberman,et al.  Clinical practice. Screening for colorectal cancer. , 2009, The New England journal of medicine.

[6]  Katherine A. Willets,et al.  Surface-enhanced Raman scattering (SERS) for probing internal cellular structure and dynamics , 2009, Analytical and bioanalytical chemistry.

[7]  Sanjiv S Gambhir,et al.  "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Kazunori Kataoka,et al.  PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .

[9]  T. Takayama,et al.  Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  C. Létoublon,et al.  EGFR in colorectal cancer: more than a simple receptor. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. D. Palma,et al.  How to choose the best preparation for colonoscopy , 2009, Nature Reviews Gastroenterology &Hepatology.

[12]  Zhen Cheng,et al.  Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. , 2010, Journal of biomedical optics.

[13]  A. Alivisatos,et al.  Isolation of discrete nanoparticle-DNA conjugates for plasmonic applications. , 2008, Nano letters.

[14]  Moungi G Bawendi,et al.  Compact biocompatible quantum dots functionalized for cellular imaging. , 2008, Journal of the American Chemical Society.

[15]  Sung Yong Park,et al.  DNA-programmable nanoparticle crystallization , 2008, Nature.

[16]  D. Lieberman,et al.  Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice , 2005, Annals of Internal Medicine.

[17]  R. G. Freeman,et al.  SERS as a Foundation for Nanoscale, Optically Detected Biological Labels , 2007 .

[18]  Luke P. Lee,et al.  Bioinspired nanocorals with decoupled cellular targeting and sensing functionality. , 2010, Small.

[19]  S. Gambhir,et al.  Noninvasive molecular imaging of small living subjects using Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[20]  S. Wexner,et al.  Oral Colorectal Cleansing Preparations in Adults , 2012, Drugs.

[21]  Ralf Kiesslich,et al.  Advances in endoscopic imaging of colorectal neoplasia. , 2010, Gastroenterology.

[22]  S. Gambhir,et al.  A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression , 2009, Journal of Nuclear Medicine.

[23]  M. Bissonnette,et al.  Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model , 2008, Clinical Cancer Research.

[24]  A. Italiano,et al.  Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Junji Kato,et al.  Aberrant Crypt Foci of the Colon as Precursors of Adenoma and Cancer , 1998 .

[26]  R. Kiesslich,et al.  Chromoendoscopy with Indigocarmine Improves the Detection of Adenomatous and Nonadenomatous Lesions in the Colon , 2001, Endoscopy.

[27]  J. Potgieter.  Adsorption of methylene blue on activated carbon: An experiment illustrating both the Langmuir and Freundlich isotherms , 1991 .

[28]  C. Larabell,et al.  Quantum dots as cellular probes. , 2005, Annual review of biomedical engineering.

[29]  S. Cross,et al.  Chromoscopic endomicroscopy: In vivo cellular resolution imaging of the colorectum , 2008, Journal of gastroenterology and hepatology.

[30]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[31]  J. B. Hall,et al.  Characterization of nanoparticles for therapeutics. , 2007, Nanomedicine.

[32]  Stuart A. Taylor,et al.  Nonlaxative PET/CT Colonography: Feasibility, Acceptability, and Pilot Performance in Patients at Higher Risk of Colonic Neoplasia , 2010, Journal of Nuclear Medicine.

[33]  D. M. Olive,et al.  In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. , 2010, Neoplasia.

[34]  T. Fujii,et al.  Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK , 2000, The Lancet.

[35]  Wei Qian,et al.  Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. , 2007, Nano letters.

[36]  R. Playford,et al.  The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. , 1996, Gut.

[37]  Christopher H Contag,et al.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. , 2008, Nature medicine.

[38]  Pamela Basto,et al.  HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy , 2008, ChemMedChem.

[39]  P. Dario,et al.  Capsule endoscopy: progress update and challenges ahead , 2009, Nature Reviews Gastroenterology &Hepatology.

[40]  S. Ståhl,et al.  Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry , 2009, Journal of Nuclear Medicine.

[41]  Zhen Cheng,et al.  Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. , 2010, Bioconjugate chemistry.

[42]  Sanjiv S. Gambhir,et al.  Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy , 2009, Proceedings of the National Academy of Sciences.

[43]  N. Shah,et al.  Surface-enhanced Raman spectroscopy. , 2008, Annual review of analytical chemistry.

[44]  I. Talbot,et al.  The prevalence of small, flat colorectal cancers in a western population , 2004, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[45]  M. Pelletier,et al.  Quantitative Analysis Using Raman Spectrometry , 2003, Applied spectroscopy.

[46]  B. Knudsen,et al.  Spectral analysis of multiplex Raman probe signatures. , 2008, ACS nano.

[47]  Shi Ke,et al.  Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. , 2007, Journal of biomedical optics.

[48]  S. Gambhir,et al.  Engineered Two‐Helix Small Proteins for Molecular Recognition , 2009, Chembiochem : a European journal of chemical biology.

[49]  M. Bertagnolli,et al.  Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.

[50]  K. Schaumburg,et al.  Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters. , 2002, Chemical communications.

[51]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[52]  D. Rockey.  Computed tomographic colonography: current perspectives and future directions. , 2009, Gastroenterology.

[53]  M. Bissonnette,et al.  Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci. , 2006, Cancer research.

[54]  M F Neurath,et al.  Colonoscopy, Tumors, and Inflammatory Bowel Disease - New Diagnostic Methods , 2006, Endoscopy.

[55]  Janina Kneipp,et al.  In vivo molecular probing of cellular compartments with gold nanoparticles and nanoaggregates. , 2006, Nano letters.

[56]  A. Hagooly,et al.  Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer , 2009, Journal of Nuclear Medicine.

[57]  J. McDevitt,et al.  Programmable nano-bio-chip sensors: analytical meets clinical. , 2010, Analytical chemistry.

[58]  M. Natan,et al.  Glass-Coated, Analyte-Tagged Nanoparticles: A New Tagging System Based on Detection with Surface-Enhanced Raman Scattering , 2003 .

[59]  David Erickson,et al.  Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow. , 2003, Journal of colloid and interface science.

[60]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[61]  D. A. Stuart,et al.  Surface-enhanced Raman spectroscopy biosensors: excitation spectroscopy for optimisation of substrates fabricated by nanosphere lithography. , 2005, IEE proceedings. Nanobiotechnology.

[62]  D. Jonas,et al.  Systematic Review: Enhancing the Use and Quality of Colorectal Cancer Screening , 2010, Annals of Internal Medicine.